| |
| Device | ORSIRO Sirolimus Eluting Coronary Stent System |
| Generic Name | Coronary drug-eluting stent |
| Applicant | Biotronik AG Ackerstrasse 6 Bülach 8180 |
| PMA Number | P170030 |
| Supplement Number | S002 |
| Date Received | 03/22/2019 |
| Decision Date | 11/12/2019 |
| Product Code |
NIQ |
| Advisory Committee |
Cardiovascular |
| Supplement Type | Normal 180 Day Track No User Fee |
| Supplement Reason | Postapproval Study Protocol |
| Expedited Review Granted? | No |
| Combination Product | Yes |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approval of the revised protocol for the post-approval study (PAS) protocol. |